More or Less · Topics · Episode #168

Claude Just Discovered a New CRISPR-Like Enzyme System — and the Timing Is Not an Accident

Clip from the full recording, 16:19–18:06 · download mp4

Anthropic says Claude used ~10,000 agents working ~21 hours to discover a new enzyme system with CRISPR-like gene-editing properties for bacteriophages — a genuine optimism story the crew reads as also, conveniently, an IPO-narrative reset.

After an episode of mostly AI skepticism, Jessica flags a real counter-data point: Claude reportedly discovered a new enzyme system — using roughly 10,000 agents working about 21 hours — with properties resembling CRISPR for editing bacteriophage genes. Dave, revealing a surprise expertise in phages (“the unsung hero nobody ever researched in America, but Russia is a grand expert in”), gets genuinely excited about the science itself.

Jessica immediately reads the announcement two ways at once: it’s legitimately cool, and it’s also obviously useful for resetting the negative AI narrative right as Anthropic’s IPO timeline is reportedly being pushed back (to around November, per some reporting). Brit predicts the next two months will be “Claude Catnip” — a wave of science-positive stories timed to the IPO — while Jessica, citing her own reporting at The Information, says the real story is more nuanced than what’s circulating.

Key points

  • Anthropic says Claude discovered a new enzyme system with CRISPR-like gene-editing properties for bacteriophages, using roughly 10,000 agents over about 21 hours of work.
  • Dave reveals an unexpected personal interest in phage research, noting it's historically under-studied in the US but a major research area in Russia.
  • Jessica reads the timing as helpful for resetting AI's negative narrative right as Anthropic's IPO is reportedly being pushed back, toward November.
  • Brit predicts the next two months will bring a wave of "Claude Catnip" stories about AI curing the world's ailments, timed to the IPO.
  • Jessica cautions that reporting on the IPO timeline (including in the Wall Street Journal) is less nuanced than what The Information has found, without detailing an unpublished story.

Where they landed

JessicaGenuinely impressed by the science, but clear-eyed that the announcement's timing conveniently serves the IPO narrative.
DaveEnthusiastic about the phage science on its own merits, says 'of course they're putting this out' given the timing.
BritExpects a sustained wave of AI-does-good-science press in the run-up to IPO.

Quotes

“We have heard that Claude has discovered a new enzyme system with about 10,000 agents and 21 hours-ish of working — a new enzyme system that appears to have properties like CRISPR for gene editing.”— Jessica
“Phages are like the unsung hero that nobody ever researched in America, but Russia is like a grand expert in.”— Dave
“The next two months are gonna be Claude Catnip, you guys. It's gonna be all the most amazing things about how they're curing the world's ailments.”— Brit

Suggested tweets

Claude reportedly just discovered a new CRISPR-like enzyme system for editing bacteriophage genes — using 10,000 agents over 21 hours. Dave Morin, it turns out, has a secret phage obsession.

Tweet this →

Brit Morin's prediction: the next two months will be wall-to-wall "Claude Catnip" stories about AI curing diseases, timed suspiciously well to Anthropic's IPO.

Tweet this →

Jessica Lessin's read on Claude's big science win: genuinely cool, and also exactly the story you'd want to be telling right as your IPO timeline slips.

Tweet this →

All topics · Full episode #168 + transcript · Subscribe on YouTube · Spotify